+20.1%
GSK vs OSCR
+64.1%
-44.0%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | OSCR | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +0.6% | -0.6% | 0.0% |
| 7D | -3.5% | +1.6% | -5.1% | -3.5% |
| 30D | -3.4% | +10.7% | -14.1% | -3.4% |
| 3M | -8.1% | +13.4% | -21.5% | -8.0% |
| 6M | -11.1% | +144.6% | -155.7% | -9.8% |
| YTD | +0.7% | +128.0% | -127.3% | +2.2% |
| 1Y | +20.1% | +68.7% | -48.5% | +20.4% |
| All | +20.1% | +64.1% | -44.0% | +20.4% |
Cumulative growth
Daily Returns
Daily percentage return beside OSCR.
Daily Out/Under-Performance
Portfolio return minus OSCR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OSCR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded OSCR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling